Keel Point LLC cut its stake in Procter & Gamble Company (The) (NYSE:PG) by 11.0% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,946 shares of the company’s stock after selling 732 shares during the period. Keel Point LLC’s holdings in Procter & Gamble Company (The) were worth $534,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Pacific Global Investment Management CO boosted its stake in Procter & Gamble Company (The) by 0.4% in the fourth quarter. Pacific Global Investment Management CO now owns 91,627 shares of the company’s stock worth $7,704,000 after buying an additional 382 shares during the period. Loomis Sayles & Co. L P boosted its stake in Procter & Gamble Company (The) by 4.9% in the fourth quarter. Loomis Sayles & Co. L P now owns 8,766,489 shares of the company’s stock worth $737,087,000 after buying an additional 406,412 shares during the period. Wallace Capital Management Inc. boosted its stake in Procter & Gamble Company (The) by 1.4% in the fourth quarter. Wallace Capital Management Inc. now owns 30,278 shares of the company’s stock worth $2,546,000 after buying an additional 432 shares during the period. SRS Capital Advisors Inc. acquired a new stake in Procter & Gamble Company (The) during the fourth quarter worth about $366,000. Finally, Janus Capital Management LLC boosted its stake in Procter & Gamble Company (The) by 7.5% in the fourth quarter. Janus Capital Management LLC now owns 2,402,396 shares of the company’s stock worth $201,994,000 after buying an additional 167,288 shares during the period. 59.69% of the stock is currently owned by institutional investors and hedge funds.

Shares of Procter & Gamble Company (PG) traded down 0.256% during midday trading on Friday, reaching $91.505. 2,903,722 shares of the company’s stock were exchanged. The stock has a market cap of $233.34 billion, a PE ratio of 16.361 and a beta of 0.68. Procter & Gamble Company has a 12 month low of $81.18 and a 12 month high of $92.08. The company’s 50 day moving average is $88.98 and its 200-day moving average is $88.90.

Procter & Gamble Company (The) (NYSE:PG) last released its earnings results on Thursday, July 27th. The company reported $0.85 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.78 by $0.07. Procter & Gamble Company (The) had a return on equity of 19.97% and a net margin of 23.56%. The firm had revenue of $16.08 billion for the quarter, compared to analysts’ expectations of $16.01 billion. During the same quarter in the previous year, the business posted $0.79 earnings per share. The business’s revenue for the quarter was down .1% on a year-over-year basis. Equities analysts forecast that Procter & Gamble Company will post $4.17 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, August 15th. Shareholders of record on Friday, July 21st will be given a $0.6896 dividend. This represents a $2.76 dividend on an annualized basis and a yield of 3.01%. The ex-dividend date is Wednesday, July 19th. Procter & Gamble Company (The)’s dividend payout ratio is presently 49.37%.

TRADEMARK VIOLATION WARNING: This report was originally posted by Daily Political and is the sole property of of Daily Political. If you are reading this report on another domain, it was illegally stolen and republished in violation of U.S. and international trademark & copyright legislation. The original version of this report can be accessed at https://www.dailypolitical.com/2017/08/11/keel-point-llc-has-534000-stake-in-procter-gamble-company-the-nysepg.html.

A number of research firms have issued reports on PG. UBS AG reiterated a “buy” rating and issued a $102.00 target price (down from $104.00) on shares of Procter & Gamble Company (The) in a research note on Friday, April 28th. Capital One Financial Corporation cut shares of Procter & Gamble Company (The) from an “overweight” rating to an “equal weight” rating and reduced their price objective for the stock from $5.00 to $2.00 in a research note on Thursday, June 22nd. Royal Bank Of Canada restated a “hold” rating and issued a $80.00 price objective on shares of Procter & Gamble Company (The) in a research note on Friday, June 30th. Sanford C. Bernstein restated an “outperform” rating and issued a $100.00 price objective (up from $98.00) on shares of Procter & Gamble Company (The) in a research note on Sunday, July 30th. Finally, Stifel Nicolaus reduced their price objective on shares of Procter & Gamble Company (The) from $88.00 to $87.00 and set a “hold” rating for the company in a research note on Thursday, April 27th. Three research analysts have rated the stock with a sell rating, eleven have issued a hold rating and seven have assigned a buy rating to the stock. Procter & Gamble Company (The) presently has a consensus rating of “Hold” and a consensus target price of $87.81.

In other Procter & Gamble Company (The) news, insider Suranjan Magesvaran sold 10,512 shares of Procter & Gamble Company (The) stock in a transaction dated Monday, July 31st. The stock was sold at an average price of $91.00, for a total value of $956,592.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Patrice Louvet sold 48,310 shares of Procter & Gamble Company (The) stock in a transaction dated Thursday, May 25th. The shares were sold at an average price of $86.79, for a total value of $4,192,824.90. Following the completion of the transaction, the insider now owns 95,340 shares in the company, valued at approximately $8,274,558.60. The disclosure for this sale can be found here. In the last quarter, insiders sold 203,898 shares of company stock worth $17,666,387. Company insiders own 0.35% of the company’s stock.

Procter & Gamble Company (The) Company Profile

The Procter & Gamble Company is focused on providing branded consumer packaged goods to the consumers across the world. The Company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care, and Baby, Feminine & Family Care. The Company sells its products in approximately 180 countries and territories primarily through mass merchandisers, grocery stores, membership club stores, drug stores, department stores, distributors, baby stores, specialty beauty stores, e-commerce, high-frequency stores and pharmacies.

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG).

Institutional Ownership by Quarter for Procter & Gamble Company (The) (NYSE:PG)

Receive News & Ratings for Procter & Gamble Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.